Navigation Links
Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
Date:12/21/2011

tion under the securities laws of any state or jurisdiction.

About Ampio

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs").  By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs. For more information about Ampio, please visit our website, www.ampiopharma.com.

Forward-Looking Statements

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, and changes in business conditions and similar events. The risks and uncertainties involved include, but are not limited to, statements relating to Ampio's ability to successfully complete the proposed offering and the use of proceeds therefrom, as well as other risks that are described in further detail in the preliminary prospectus supplement relating to the offering and in Ampio's filings with the Securities and Exchange Commission, including Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Responds to Recent Publications by Anonymous Short Sellers
2. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
3. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
4. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
5. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
6. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
7. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
8. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
9. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
10. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
11. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) ... November 30, 2013, compared to sales of $2,202,000 for the ... again, this quarter has also shown growth over the preceding ... quarter of this fiscal year. Markets that experienced sales increases ...
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules -- HARBIN, China, Aug. 19 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... 18 GeneLink, Inc. (OTC Bulletin Board: ... for the fiscal quarter ended June 30, 2010. ... operating loss reduced by 35% over Q2 2009 Comparable quarter ... Month Revenues of $4,240,177 compared to $4,085,215 in the first six ...
Cached Medicine Technology:Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 2Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 3Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 4Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 5Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 6Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 7GeneLink Reports Second Quarter Improvement 2
(Date:7/10/2014)... July 10, 2014 Ticketability.com has a wide ... now Paul McCartney tickets for San Diego are being added ... Diego since 1976, and the newly added September 28 show ... , Click Here to view the selection of ... Petco Park will become available to the general public on ...
(Date:7/10/2014)... July 10, 2014 CBPartners, a global ... has launched a new website. The redesigned site ... increased access to the firm’s thought pieces, blog posts, ... ideal platform to showcase our insights, capabilities, and to ... CBPartners’ Chief Executive Officer, Cyrus Chowdhury. “An enhanced ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 ... the latest results of the 4th “Trending in ... suite model. , Every day multinational corporations ... contracts, expense forms etc. To meet this challenge, ... (S2P) suites which can be defined as a ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Adults with dyslexia are ... as children or teenagers than people who don,t have ... Dyslexia, which affects up to 10 percent of ... that 35 percent of adults with this condition said ... 7 percent of those without dyslexia. "Even after ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, ... make use of calorie information on menus, if it,s available, ... new U.S. study. Women in particular review the menu ... epidemiologist with the U.S. Centers for Disease Control and Prevention. ... labeling to help choose their meal, compared with just under ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:CBPartners Announces New Website 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3
... Pa., March 2 Herley Industries, Inc. (Nasdaq: ... received contract awards totaling approximately $1 million from the U. ... assemblies and radar components. The awards are for the ... the B1 Bomber and radar components for use in the ...
... MEMPHIS, Tenn., March 2 Accelerated Community Oncology ... announced today the highlights of its annual Principal ... Medical oncologists from community-based oncology practices throughout ... cancer research advances, emerging treatment trends, as well ...
... Triple-S,Management Corporation (NYSE: GTS ) today announced ... Juan-Jose Roman, Finance Vice,President & CFO, will host an ... The presentation will be broadcast live through the ... access the webcast at the Triple-S,Management website at ...
... brings experience as CIO and HIMSS executive; Shirley Hughes ... mobility companyHATBORO, Pa., March 2 InfoLogix, Inc. ... provider of enterprise mobility solutions for the healthcare and ... has joined Healthcare Informatics Associates (HIA), an ...
... Pa., March 2 The first Eklin RapidStudy(TM),digital ... installed at Dr.,Flake,s Animal Wellness Clinic which serves ... The state-of-the-art system,from Eklin Medical Systems, the leader ... the area,s thousands of veterinary patients,supporting the Clinic,s ...
... March 2 Boston Scientific Corporation (NYSE: BSX ... elected John E. Sununu as a Director. For the ... from New Hampshire. He was a member of the ... was appointed the Congressional Representative to the United Nations General ...
Cached Medicine News:Health News:Herley Lancaster Awarded $1.0 Million in New Contracts 2Health News:ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting 2Health News:ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting 3Health News:Triple-S Management Corporation to Host Inaugural Investor Day on March 5, 2009 2Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 2Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 3Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 4Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 2Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 2Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 4
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
... The NMP22 BladderChek Test is the only ... diagnosis of bladder cancer. The NMP22 BladderChek Test ... a single urine sample, that detects elevated levels ... small amounts of NMP22 protein in the urine. ...
... The NMP22® Test Kit is a quantitative ... NMP22 protein. Healthy individuals generally have very small ... the level of NMP22 protein is often elevated ... even at early stages of the disease. The ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
Medicine Products: